SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Ramat David Air Base may have been hit during latest Israel-Iran escalation

The Middle East’s new normal: Brief wars, constant economic exposure

Dazz founder Merav Bahat leaves Wiz after Google deal, eyes new cyber-AI venture

Israel’s Smart Shooter lands new U.S. Marine Corps contract as drone warfare drives procurement surge

Buzz

Most popular

Daily

Weekly

1

Iron Dome and Iron Beam maker Rafael at center of Israeli government clash over IPO plan

2

A Security raises $37 million backed by Wiz CEO Assaf Rappaport and Cyera CEO Yotam Segev

3

AI startup fighting traffic fines faces shutdown by Israel’s bar association

4

Former unicorn Hailo cuts 50% of workforce amid funding pressure and strategic reset

5

PointFive raises $60 million Series B to help companies survive the AI cost explosion

Ibex Medical Analytics

6 stories about Ibex Medical Analytics

מייסדי אייבקס, מימין: ד"ר חיים לינהרט ויוסי מוסל

Ibex Medical raises $55 million Series C for AI-powered cancer diagnostics

06.09.23|Meir Orbach

The Israeli startup’s platform provides health systems and diagnostic laboratories with an integrated solution for cancer diagnosis and biomarker scoring, capable of detecting more than 100 different cancer and non-cancer pathologies

Ibex Medical Analytics

RISE & align: Assuta’s innovation arm to partner with five additional healthtech startups

The technologies include everything from artificial intelligence for cancer pathology diagnosis and innovative blood test for the diagnosis of diverse diseases in a single blood test to accurate technology for colonoscopy

אייבקס אנליטיקס ibex analytics

Roche partners with Ibex Medical Analytics for AI-assisted cancer detection

The Israeli AI-based cancer diagnostics startup will jointly develop an embedded image analysis workflow for pathologists to help diagnose early cancer detection

Ibex Medical Analytics granted ‘Breakthrough Device Designation’ by the FDA, fast-tracking its approval

09.06.21|James Spiro

The U.S Food and Drug Administration formally acknowledged its Galen platform and the potential benefit it has on American patients

IBEX CE approved

Ibex obtains CE Mark for AI-powered breast cancer detection

26.05.21|James Spiro

The Ibex Galen Breast solution can detect multiple types of breast cancer and provide accurate diagnoses

Ibex Medical Analytics raises $38 million for AI-powered cancer diagnostics solutions

09.03.21|Meir Orbach

Ibex’s solutions detect cancer in real-time, enabling 100% quality control, while also reducing turnaround times